Orgenesis Inc. Files Current Report

Ticker: ORGS · Form: 8-K · Filed: May 31, 2024 · CIK: 1460602

Orgenesis INC. 8-K Filing Summary
FieldDetail
CompanyOrgenesis INC. (ORGS)
Form Type8-K
Filed DateMay 31, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: listing, corporate-info

Related Tickers: ORGS

TL;DR

ORGS filed an 8-K, confirming Nasdaq listing. No major news.

AI Summary

Orgenesis Inc. (ORGS) reported on May 31, 2024, that its common stock is traded on The Nasdaq Capital Market. The company is incorporated in Nevada and has its principal executive offices in Germantown, MD. This filing is a current report (Form 8-K) and does not appear to contain specific financial transactions or material events beyond the basic company information and listing details.

Why It Matters

This filing confirms Orgenesis Inc.'s status as a publicly traded company on Nasdaq, providing basic corporate information. Investors can use this to verify listing details and company registration.

Risk Assessment

Risk Level: low — This filing is a routine current report (8-K) that primarily confirms basic corporate information and stock exchange listing, without disclosing new material financial events or risks.

Key Players & Entities

FAQ

What is the trading symbol for Orgenesis Inc.'s common stock?

The trading symbol for Orgenesis Inc.'s common stock is ORGS.

On which exchange is Orgenesis Inc.'s common stock registered?

Orgenesis Inc.'s common stock is registered on The Nasdaq Capital Market.

In which state is Orgenesis Inc. incorporated?

Orgenesis Inc. is incorporated in Nevada.

What is the date of the earliest event reported in this Form 8-K?

The date of the earliest event reported is May 31, 2024.

What is the principal executive office address for Orgenesis Inc.?

The principal executive office address is 20271 Goldenrod Lane, Germantown, MD 20876.

Filing Stats: 641 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2024-05-31 06:14:05

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: May 31, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing